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Background: Microparticles (MPs) are 0.1-1 μm membrane-shed vesicles
released following cell activation/apoptosis. Little is known about how MPs
release in the ischemic myocardium. We aimed to evaluate the cardiac MPs
release after myocardial infarction (MI) in diabetic mice.
Methods: C57BL/6 mice were treated by streptozotocin and coronary
artery ligation was performed during 6 hours to 72 hours at the end of
12 weeks’ hyperglycemia. MPs from both sham and ischemic myocardial
muscles obtained from control and diabetic mice were isolated after sequential
centrifugation. Flow cytometry analysis quantified the peak formation of
phosphatidylserine+MPs (PS+MPs) using annexin V. Plasma MPs were also
analyzed and compared to those observed in cardiac tissues. A GFP-α-actin
transgenic mouse model was used to characterize the GFP packing in cardiac
MPs.
Results: PS-rich MPs were measurable in the mouse heart. In control mice,
cardiac MP level increased till 15 hours after ligation, then returned to a basal
level 72 hours later. In diabetic mice, myocardial MP increase following MI
was delayed and more transient than in control mice after onset of coronary
arteries ligation. Cardiac MP levels showed no significant difference between
diabetic mice and control mice. Cardiac MPs were also isolated from GFP-α-
actin transgenic mice heart. 39% PS+MPs showed GFP+, demonstrating that
they were originating from cardiomyocytes. The platelet-free plasma of
control mice contained extremely low levels of PS+MPs. Plasma MP levels
were higher in diabetic mice than in control mice.
Conclusion: This study reports for the first time that coronary artery liga-
tion transiently increases local MPs generation in mouse heart, in particular
those originating from cardiomyocytes. MPs levels were increased in both
plasma and heart of diabetic mice, where they could contribute to disease pro-
gression.
0254
Soluble adenylyl cyclase regulates cardiac mitochondrial membrane
permeabilization under calcium stress
Zhenyu Wang (1), Claire Nicolas (1), Delphine Courilleau (2), Gregoire
Vandecasteele (1), Rodolphe Fischmeister (1), Catherine Brenner (1)
(1)Inserm U 769, Châtenay-Malabry, France – (2) IFR141-Ciblot, Châte-
nay-Malabry, France
cAMP is an important messenger of neurohormonal regulation of the heart.
cAMP regulates many cellular functions such as gene expression, excitation-
contraction coupling and cellular metabolism. cAMP is produced by adenylyl
cyclases (AC) and degraded by phosphodiesterases (PDEs). Most AC iso-
forms are membrane proteins except a bicarbonate (HCO3-)-regulated soluble
isoform (sAC). The existence and role of a sAC/cAMP signaling in mitochon-
dria has been postulated in various tissues including liver (1), brain (2) and
neonatal cardiomyocytes (3), but has not been demonstrated in adult cardio-
myocytes. The goal of this study was to demonstrate the existence of a mito-
chondrial cAMP-signalling pathway and explore its influence on
mitochondrial function and cell fate. To that end, cardiac mitochondria were
isolated as a homogenous, pure and functional suspension from adult rat and
mouse heart. sAC, exchange proteins directly activated by cAMP (Epac1 and
2) and PDEs were co-detected with constitutive proteins such as ANT and
VDAC in mitochondria. At low respiratory substrate concentration, HCO3–
activated sAC-dependent cAMP production and hyperpolarized the mitochon-
drial membrane independently of pH. At high respiratory substrate concentra-
tion, HCO3– maintained the membrane potential and delayed matrix swelling
and cytochrome c release under Ca2+ stress. Moreover, cAMP production stim-
ulated mitochondrial oxygen consumption. The implication of PDEs, Epac and
PKA is currently under investigation using pharmacological modulators. In
conclusion, sAC can regulate mitochondrial membrane permeabilization and
stimulate mitochondrial respiration in adult cardiomyocytes. This might con-
stitute a novel cardioprotective mechanism through preservation of mitochon-
drial function in pathophysiological conditions of calcium overload.
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Microparticles are deemed true biomarkers and vectors of biological infor-
mation between cells. Depending on their origin, the composition of micropar-
ticles varies and the subsequent message transported by them, such as
proteins, mRNA, or miRNA, can differ. In obstructive sleep apnea syndrome
(OSAS), circulating microparticles are associated with endothelial dysfunction
by reducing endothelial-derived nitric oxide production. Here, we have ana-
lyzed the potential role of circulating microparticles from OSAS patients on
the regulation of angiogenesis and the involved pathway. For this, microparti-
cles from twenty OSA patients and fifteen non-OSA subjects were used. Both
VEGF plasma levels and content carried by circulating microparticles from
OSAS patients were increased when compared with microparticles from non-
OSAS patients. Neither microparticles from OSAS or non-OSAS patients
affect endothelial cell apoptosis and migration. However, microparticles from
OSA patients but not from those non-OSA subjects enhanced endothelial cell
proliferation. Circulating microparticles from OSAS patients induced an
increase of angiogenesis in human aortic endothelial cells that was abolished
in the presence of the antagonist of endothelin-1 receptor type B. In addition,
endothelin-1 secretion was increased in human endothelial cells treated by
OSAS microparticles. We highlight that circulating microparticles from OSAS
patients can modify the secretome of endothelial cells leading to angiogenesis.
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Each year, 750 000 cases of septic shock occurs in the US. Nöt et al.
(2010) showed that O-GlcNAc stimulation, the final product of hexosamine
biosynthetic pathway (HBP), could improve patient outcome in haemorrhagic
shock. We postulated that early stimulation of the HBP in septic shock could
be of interest to improve patient survival. So we investigated two different
ways of O-GlcNAc stimulation: by increasing its activation by addition of glu-
cosamine (GLCN), or by inhibiting O-GlcNAcylation degradation by an
inhibitor of O-GlcNAcase (NbutGT).
Twelve weeks-old SD rats received either lipopolysaccharide (LPS, 5 mg/kg)
or saline intravenously (IV). One hour later, fluid resuscitation (15 mL/kg of
colloid) was associated or not with GLCN (270 mg/kg) or NbutGT (50 mg/kg).
Blood pressure was recorded during all the protocol. Three hours later, heart and
blood samples were collected to evaluate HBP by western blot (global protein
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